Bacterial Genome Variability and Its Impact on Vaccine Design

Cell Host and Microbe

Volumn 3, Issue 6, 2008, Pages 408-416

  Telford, John L ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HELICOBACTER PYLORI VACCINE; MENINGOCOCCUS VACCINE; NEISSERIA GONORRHOEAE VACCINE; NEUTRALIZING ANTIBODY; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; STREPTOCOCCUS GROUP A VACCINE;

ANTIGENIC VARIATION; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CARBOHYDRATE ANALYSIS; CLINICAL TRIAL; DRUG DESIGN; DRUG EFFICACY; DRUG STRUCTURE; GENE EXPRESSION; GENETIC VARIABILITY; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTYPE; STRUCTURE ANALYSIS; VACCINE PRODUCTION;

ANIMALS; ANTIGENIC VARIATION; ANTIGENS, BACTERIAL; BACTERIA; BACTERIAL PROTEINS; BACTERIAL VACCINES; GENE EXPRESSION; GENOME, BACTERIAL; HUMANS; POLYSACCHARIDES, BACTERIAL; VARIATION (GENETICS);

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE;

EID: 44649137890     PISSN: 19313128     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chom.2008.05.004     Document Type: Review

References (82)

1. Alm R.A., Ling L.S., Moir D.T., King B.L., Brown E.D., Doig P.C., Smith D.R., Noonan B., Guild B.C., deJonge B.L., et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397 (1999) 176-180
2. Aspholm M., Kalia A., Ruhl S., Schedin S., Arnqvist A., Linden S., Sjostrom R., Gerhard M., Semino-Mora C., Dubois A., et al. Helicobacter pylori adhesion to carbohydrates. Methods Enzymol. 417 (2006) 293-339
3. Atherton J.C. The clinical relevance of strain types of Helicobacter pylori. Gut 40 (1997) 701-703
4. Atherton J.C. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu. Rev. Pathol. 1 (2006) 63-96
5. Atherton J.C., Cao P., Peek Jr. R.M., Tummuru M.K., Blaser M.J., and Cover T.L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270 (1995) 17771-17777
6. Bagnoli F., Buti L., Tompkins L., Covacci A., and Amieva M.R. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc. Natl. Acad. Sci. USA 102 (2005) 16339-16344
7. Baker C.J., and Kasper D.L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N. Engl. J. Med. 294 (1976) 753-756
8. Bayliss C.D., van de Ven T., and Moxon E.R. Mutations in polI but not mutSLH destabilize Haemophilus influenzae tetranucleotide repeats. EMBO J. 21 (2002) 1465-1476
9. Bisno A.L., Brito M.O., and Collins C.M. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3 (2003) 191-200
10. Brehony C., Jolley K.A., and Maiden M.C. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol. Rev. 31 (2007) 15-26
11. Bucci C., Lavitola A., Salvatore P., Del Giudice L., Massardo D.R., Bruni C.B., and Alifano P. Hypermutation in pathogenic bacteria: frequent phase variation in meningococci is a phenotypic trait of a specialized mutator biotype. Mol. Cell 3 (1999) 435-445
12. Carrat F., and Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 25 (2007) 6852-6862
13. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky M., Rappuoli R., and Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93 (1996) 14648-14653
14. Cieslewicz M.J., Chaffin D., Glusman G., Kasper D., Madan A., Rodrigues S., Fahey J., Wessels M.R., and Rubens C.E. Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect. Immun. 73 (2005) 3096-3103
15. Covacci A., Telford J.L., Del Giudice G., Parsonnet J., and Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 284 (1999) 1328-1333
16. Covacci A., Telford J.L., Del Giudice G., Parsonnet J., and Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 284 (1999) 1328-1333
17. Cunningham M.W. Pathogenesis of group A streptococcal infections and their sequelae. Adv. Exp. Med. Biol. 609 (2008) 29-42
18. Dale J.B. Current status of group A streptococcal vaccine development. Adv. Exp. Med. Biol. 609 (2008) 53-63
19. Dawid S., Barenkamp S.J., and St Geme III J.W. Variation in expression of the Haemophilus influenzae HMW adhesins: a prokaryotic system reminiscent of eukaryotes. Proc. Natl. Acad. Sci. USA 96 (1999) 1077-1082
20. De Jesus N.H. Epidemics to eradication: the modern history of poliomyelitis. Virol. J. 4 (2007) 70
21. Falush D., Wirth T., Linz B., Pritchard J.K., Stephens M., Kidd M., Blaser M.J., Graham D.Y., Vacher S., Perez-Perez G.I., et al. Traces of human migrations in Helicobacter pylori populations. Science 299 (2003) 1582-1585
22. Galiza E.P., and Heath P.T. Pneumococcal conjugate vaccines. A review. Minerva Med. 98 (2007) 131-143
23. Giuliani M.M., Adu-Bobie J., Comanducci M., Arico B., Savino S., Santini L., Brunelli B., Bambini S., Biolchi A., Capecchi B., et al. A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. USA 103 (2006) 10834-10839
24. Hammerschmidt S., Muller A., Sillmann H., Muhlenhoff M., Borrow R., Fox A., van Putten J., Zollinger W.D., Gerardy-Schahn R., and Frosch M. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol. Microbiol. 20 (1996) 1211-1220
25. Harrison L.H., Elliott J.A., Dwyer D.M., Libonati J.P., Ferrieri P., Billmann L., and Schuchat A. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J. Infect. Dis. 177 (1998) 998-1002
26. Hilleman M.R. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20 (2002) 3068-3087
27. Israel D.A., Salama N., Krishna U., Rieger U.M., Atherton J.C., Falkow S., and Peek Jr. R.M. Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc. Natl. Acad. Sci. USA 98 (2001) 14625-14630
28. Johnson S.C., Chung R.C., Deal C.D., Boslego J.W., Sadoff J.C., Wood S.W., Brinton Jr. C.C., and Tramont E.C. Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilin. J. Infect. Dis. 163 (1991) 128-134
29. Karnholz A., Hoefler C., Odenbreit S., Fischer W., Hofreuter D., and Haas R. Functional and topological characterization of novel components of the comB DNA transformation competence system in Helicobacter pylori. J. Bacteriol. 188 (2006) 882-893
30. Korber B., Gaschen B., Yusim K., Thakallapally R., Kesmir C., and Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br. Med. Bull. 58 (2001) 19-42
31. Lachenauer C.S., Kasper D.L., Shimada J., Ichiman Y., Ohtsuka H., Kaku M., Paoletti L.C., Ferrieri P., and Madoff L.C. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J. Infect. Dis. 179 (1999) 1030-1033
32. Lancefield R.C. Persistence of type-specific antibodies in man following infection with group A streptococci. J. Exp. Med. 110 (1959) 271-292
33. Lancefield R.C., and Perlmann G.E. Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus. J. Exp. Med. 96 (1952) 71-82
34. Lauer P., Rinaudo C.D., Soriani M., Margarit I., Maione D., Rosini R., Taddei A.R., Mora M., Rappuoli R., Grandi G., and Telford J.L. Genome analysis reveals pili in Group B Streptococcus. Science 309 (2005) 105
35. Lin F.Y., Philips III J.B., Azimi P.H., Weisman L.E., Clark P., Rhoads G.G., Regan J., Concepcion N.F., Frasch C.E., Troendle J., et al. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. J. Infect. Dis. 184 (2001) 1022-1028
36. Lin F.Y., Weisman L.E., Azimi P.H., Philips III J.B., Clark P., Regan J., Rhoads G.G., Frasch C.E., Gray B.M., Troendle J., et al. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J. Infect. Dis. 190 (2004) 928-934
37. Lipsitch M., and O'Hagan J.J. Patterns of antigenic diversity and the mechanisms that maintain them. J. R. Soc. Interface 4 (2007) 787-802
38. Maione D., Margarit I., Rinaudo C.D., Masignani V., Mora M., Scarselli M., Tettelin H., Brettoni C., Iacobini E.T., Rosini R., et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309 (2005) 148-150
39. Marchetti M., Arico B., Burroni D., Figura N., Rappuoli R., and Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 267 (1995) 1655-1658
40. Marrs C.F., Zhang L., and Foxman B. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?. FEMS Microbiol. Lett. 252 (2005) 183-190
41. Martin P., Sun L., Hood D.W., and Moxon E.R. Involvement of genes of genome maintenance in the regulation of phase variation frequencies in Neisseria meningitidis. Microbiology 150 (2004) 3001-3012
42. Mascher T., Helmann J.D., and Unden G. Stimulus perception in bacterial signal-transducing histidine kinases. Microbiol. Mol. Biol. Rev. 70 (2006) 910-938
43. Medini D., Donati C., Tettelin H., Masignani V., and Rappuoli R. The microbial pangenome. Curr. Opin. Genet. Dev. 15 (2005) 589-594
44. Mond J.J., and Kokai-Kun J.F. The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens. Curr. Top. Microbiol. Immunol. 319 (2008) 17-40
45. Montecucco C., and de Bernard M. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect. 5 (2003) 715-721
46. Mora M., Bensi G., Capo S., Falugi F., Zingaretti C., Manetti A.G., Maggi T., Taddei A.R., Grandi G., and Telford J.L. Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens. Proc. Natl. Acad. Sci. USA 102 (2005) 15641-15646
47. Morgan R.L., Isaacson R.E., Moon H.W., Brinton C.C., and To C.C. Immunization of suckling pigs against enterotoxigenic Escherichia coli-induced diarrheal disease by vaccinating dams with purified 987 or K99 pili: protection correlates with pilus homology of vaccine and challenge. Infect. Immun. 22 (1978) 771-777
48. Moxon R., Bayliss C., and Hood D. Bacterial contingency loci: the role of simple sequence DNA repeats in bacterial adaptation. Annu. Rev. Genet. 40 (2006) 307-333
49. Murphy G.L., Connell T.D., Barritt D.S., Koomey M., and Cannon J.G. Phase variation of gonococcal protein II: Regulation of gene expression by slipped-strand mispairing of a repetitive DNA sequence. Cell 56 (1989) 539-547
50. Pappenheimer Jr. A.M. Diphtheria toxin. Annu. Rev. Biochem. 46 (1977) 69-94
51. Pizza M., Scarlato V., Masignani V., Giuliani M.M., Arico B., Comanducci M., Jennings G.T., Baldi L., Bartolini E., Capecchi B., et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287 (2000) 1816-1820
52. Preston A., Parkhill J., and Maskell D.J. The bordetellae: lessons from genomics. Nat. Rev. Microbiol. 2 (2004) 379-390
53. Rappuoli R. Acellular pertussis vaccines: a turning point in infant and adolescent vaccination. Infect. Agents Dis. 5 (1996) 21-28
54. Rappuoli R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 19 (2001) 2688-2691
55. Reyrat J.M., Pelicic V., Papini E., Montecucco C., Rappuoli R., and Telford J.L. Towards deciphering the Helicobacter pylori cytotoxin. Mol. Microbiol. 34 (1999) 197-204
56. Richardson A.R., and Stojiljkovic I. Mismatch repair and the regulation of phase variation in Neisseria meningitidis. Mol. Microbiol. 40 (2001) 645-655
57. Rosini R., Rinaudo C.D., Soriani M., Lauer P., Mora M., Maione D., Taddei A., Santi I., Ghezzo C., Brettoni C., et al. Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae. Mol. Microbiol. 61 (2006) 126-141
58. Rossi G., Ruggiero P., Peppoloni S., Pancotto L., Fortuna D., Lauretti L., Volpini G., Mancianti S., Corazza M., Taccini E., et al. Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy. Infect. Immun. 72 (2004) 3252-3259
59. Ruggiero P., Peppoloni S., Rappuoli R., and Del Giudice G. The quest for a vaccine against Helicobacter pylori: how to move from mouse to man?. Microbes Infect. 5 (2003) 749-756
60. Salama N., Guillemin K., McDaniel T.K., Sherlock G., Tompkins L., and Falkow S. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc. Natl. Acad. Sci. USA 97 (2000) 14668-14673
61. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11 (1998) 497-513
62. Schuchat A. Group B streptococcus. Lancet 353 (1999) 51-56
63. Silverman M., Zieg J., Hilmen M., and Simon M. Phase variation in Salmonella: genetic analysis of a recombinational switch. Proc. Natl. Acad. Sci. USA 76 (1979) 391-395
64. Snyder L.A., Butcher S.A., and Saunders N.J. Comparative whole-genome analyses reveal over 100 putative phase-variable genes in the pathogenic Neisseria spp. Microbiology 147 (2001) 2321-2332
65. Sood R.K., and Fattom A. Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins. Expert Opin. Investig. Drugs 7 (1998) 333-347
66. Stein D.M., Robbins J., Miller M.A., Lin F.Y., and Schneerson R. Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?. Vaccine 24 (2006) 221-228
67. Stephens D.S., Spellman P.A., and Swartley J.S. Effect of the (alpha 2→8)-linked polysialic acid capsule on adherence of Neisseria meningitidis to human mucosal cells. J. Infect. Dis. 167 (1993) 475-479
68. Stephens D.S., Greenwood B., and Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369 (2007) 2196-2210
69. Suerbaum S., and Achtman M. Helicobacter pylori: recombination, population structure and human migrations. Int. J. Med. Microbiol. 294 (2004) 133-139
70. Taylor C.M., and Roberts I.S. Capsular polysaccharides and their role in virulence. Contrib. Microbiol. 12 (2005) 55-66
71. Telford J.L., Ghiara P., Dell'Orco M., Comanducci M., Burroni D., Bugnoli M., Tecce M.F., Censini S., Covacci A., Xiang Z., et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179 (1994) 1653-1658
72. Tettelin H., Saunders N.J., Heidelberg J., Jeffries A.C., Nelson K.E., Eisen J.A., Ketchum K.A., Hood D.W., Peden J.F., Dodson R.J., et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287 (2000) 1809-1815
73. Tettelin H., Masignani V., Cieslewicz M.J., Eisen J.A., Peterson S., Wessels M.R., Paulsen I.T., Nelson K.E., Margarit I., Read T.D., et al. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc. Natl. Acad. Sci. USA 99 (2002) 12391-12396
74. Tettelin H., Masignani V., Cieslewicz M.J., Donati C., Medini D., Ward N.L., Angiuoli S.V., Crabtree J., Jones A.L., Durkin A.S., et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pangenome". Proc. Natl. Acad. Sci. USA 102 (2005) 13950-13955
75. Toltzis P., and Jacobs M.R. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use. Infect. Dis. Clin. North Am. 19 (2005) 629-645
76. Tomb J.F., White O., Kerlavage A.R., Clayton R.A., Sutton G.G., Fleischmann R.D., Ketchum K.A., Klenk H.P., Gill S., Dougherty B.A., et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388 (1997) 539-547
77. van Ham S.M., van Alphen L., Mooi F.R., and van Putten J.P. Phase variation of H. influenzae fimbriae: Transcriptional control of two divergent genes through a variable combined promoter region. Cell 73 (1993) 1187-1196
78. Vogel U., Hammerschmidt S., and Frosch M. Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med. Microbiol. Immunol. (Berl.) 185 (1996) 81-87
79. Wirth T., Wang X., Linz B., Novick R.P., Lum J.K., Blaser M., Morelli G., Falush D., and Achtman M. Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh. Proc. Natl. Acad. Sci. USA 101 (2004) 4746-4751
80. Yother J. Common themes in the genetics of streptococcal capsular polysaccharides. In: Goldberg J. (Ed). Genetics of Bacterial Polysaccharides (1999), CRC Press, Boca Raton, FL 161-184
81. Zaleznik D.F., Rench M.A., Hillier S., Krohn M.A., Platt R., Lee M.L., Flores A.E., Ferrieri P., and Baker C.J. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin. Infect. Dis. 30 (2000) 276-281
82. Zieg J., Silverman M., Hilmen M., and Simon M. Recombinational switch for gene expression. Science 196 (1977) 170-172